| Lithobid Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Lithobid 300 mg | tablet, extended release | oral | 1.0 each | OTC |
Posted by princess2aa over 2 years ago
the shakes, stomache,a rash on my chest and on the back of my neck.
Posted by rocahotgirl over 5 years ago
dizzy
Posted by rivambm over 5 years ago
hand tremors, decreased balance, dry mouth and eyes, twitches
Noven Appoints Michael D. Price Chief Financial Officer - Genetic Engineering News (press release)
Products currently marketed through the Noven/JDS sales infrastructure consist of Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium carbonate). ...
Thu Nov 15 17:37:23 -0500 2007
Noven Announces Results of Phase 3 Clinical Study of Once-Daily ... - Business Wire (press release)
all 23 news articles
Mon Oct 08 05:06:52 -0400 2007
Noven Announces Share Repurchase Program - PharmaLive.com (press release)
Products currently marketed through the JDS psychiatry sales infrastructure include Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium carbonate). ...
Wed Sep 05 05:54:13 -0400 2007
lithium carbonate - The carbonate salt of lithium, a monovalent cation with antimanic activity. Lithium carbonate interferes with transmembrane sodium exchange in nerve cells by affecting sodium, potassium-stimulated adenosine triphosphatase (Na+, K+-ATPase); altering the release of neurotransmitters; reducing cyclic adenosine monophosphate (cAMP) concentrations and modulating cAMP second-messenger processes; and suppressing signal transduction pathways through the depletion of intracellular inositol and inhibition of the enzyme, glycogen synthase-kinase-3 (GSK-3). The exact mechanism through which lithium carbonate exerts its mood-stabilizing effect is not fully known.